Skip to main content
. 2019 Sep 25;12:1756284819878660. doi: 10.1177/1756284819878660

Figure 2.

Figure 2.

Overall survival in folfirinox and gemcitabine/nab-paclitaxel groups before and after matching on propensity score.

CI, confidence interval; HR, hazard ratio.